Synaptic Vesicle
Overview of Synaptic Vesicle in Nervous Systems
Communication in the central and peripheral nervous systems via neurons is mediated by the regulated release of chemical messenger molecules, neurotransmitters. Neurons communicate with other cells through synaptic transmission. The presynaptic nerve terminal is filled with small organelles loaded with a cocktail of physiologically active small molecules. Neurotransmitter release from the presynaptic terminal is triggered by calcium influx. The secreted transmitter molecules induce a physiological response by binding to appropriate receptors. Uptake, storage, and stimulus-dependent release of neurotransmitters are maintained by highly specialized organelles, the synaptic vesicles. These are key organelles in synaptic transmission and many of their numerous tasks are governed by proteins as carriers of function. A detailed characterization of synaptic vesicle-associated proteins will greatly contribute to our further understanding of the molecular mechanisms underlying intercellular communication.
Introduction of Synaptic Vesicles
Synaptic vesicles contain two classes of obligatory components: transport proteins involved in neurotransmitter uptake, and trafficking proteins that participate in synaptic vesicle exo- and endocytosis and recycling. Transport proteins are composed of a vacuolar-type proton pump that generates the electrochemical gradient, which fuels neurotransmitter uptake, and neurotransmitter transporters that mediate the actual uptake. The trafficking proteome of synaptic vesicles is complex. It includes intrinsic membrane proteins, proteins associated via posttranslational lipid modifications, and peripherally bound proteins. These proteins do not share a characteristic that would make them identifiable as synaptic vesicle proteins, and little is known about how these proteins are specifically deposited into synaptic vesicles. Many but not all of the known synaptic vesicle proteins interact with nonvesicular proteins and are linked to specific functions.
Fig.1 Major molecular constituents of cholinergic synaptic vesicles. (Volknandt, 1995)
Synaptic Vesicle Pools
When a nerve terminal is stimulated repeatedly at a high rate, release drops dramatically and eventually reaches a lower steady-state level. The use-dependent initial synaptic depression during high-frequency stimulation reflects the depletion of vesicles in the readily releasable pool. The steady-state level of release corresponds to the rate with which vesicles are replenished into the readily releasable pool by recycling or by recruitment from a reserve pool. The concept of equating release rates with vesicle pools has been useful, and different pools of synaptic vesicles were defined based on the rates of release under various stimulation conditions.
Most synapses rely on three vesicle pools:
Readily releasable pool (RRP): Presynaptic nerve terminals contain a RRP, from which vesicles can be easily mobilized on stimulation;
Reserve pool: Presynaptic nerve terminals contain a large reserve pool, from which vesicles are drawn more slowly, typically in response to intense or prolonged stimulation.
Recycling pool: Recycling pool is released more slowly than the readily releasable pool, and its release precedes reserve pool mobilization.
Table.1 Characteristics of the vesicle pools
Pool | Readily releasable pool (RRP) | Recycling pool | Reserve pool< |
Size (% of all vesicles) | ~1-2% | ~10-20% | ~80-90% |
Location | Docked | Scattered | Scattered (bulk of vesicle cluster) |
Released within | <1 second | A few seconds | Tens of seconds, minutes |
Recycling | Fast (seconds) | Fast (seconds) | Slow (minutes) |
Mixing with | Fast mixing with | Slow mixing | Slow mixing with |
Other pools | recycling vesicles | with reserve | other vesicles |
Mobility in resting terminals | None - docked | High | Low (high in bipolar cells) |
Creative Biolabs is a professional in providing neuro-based services and products. We are dedicated in offering customer-satisfied services all the time.
If you are working on neuro research, or you have any other questions about our services, please don’t hesitate to contact us for more information.
Reference
- Volknandt, W. The synaptic vesicle and its targets. Neuroscience. 1995, 64(2): 277-300.
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P517) (Cat#: NRP-0422-P517)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P515) (Cat#: NRP-0422-P515)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody(NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- NeuroMab™ Anti-GARP Antibody(NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Green Fluorescent Tau SH-SY5Y cell Line (Cat#: NCL2110P219)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)